Anti-Kickback Statute - G2 Intelligence

Special Report: The 2024 Lab Enforcement Landscape

Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing

Start a Free Trial for immediate access to this article

Already a member? Log in here

Genetic testing related fraud was a theme in recent enforcement actions involving medical laboratories and lab testing

Start a Free Trial for immediate access to this article

Already a member? Log in here

Examining DOJ and OIG investigations of labs and their owners: Recent cases show continued focus on the usual enforcement targets.

Start a Free Trial for immediate access to this article

Already a member? Log in here

How to avoid six common compliance risks involving free supplies, equipment, software, and other non-monetary compensation

Start a Free Trial for immediate access to this article

Already a member? Log in here

Know where labs may fall foul of compliance requirements—and discover the actions your lab can take to mitigate the risk of noncompliance

Start a Free Trial for immediate access to this article

Already a member? Log in here